Zizion Group Creates Dedicated Regenerative Therapy Division.

Share Article

Zizion Group launches new division RegenOMedix dedicated to helping physicians deploy Regenerative Therapies to their patient base.

Zizion Group, an internationally focused medical device distributor located in South Florida has launched a new division dedicated to bringing cutting edge FDA approved Regenerative Therapy solutions to the medical community.

“Our new division, RegenOMedix works to identify the most efficacious solutions in regenerative medicine available today,” stated Bruce Bertman, CEO of Zizion Group. “We have identified several leading products such as Platelet Rich Plasma and Human Allograft tissues that have shown incredible success when treating muscular skeletal indications with tissue damage.” Bertman continued, “Our vendors are providing cutting edge, high quality and proven products that are FDA cleared. We distribute these and help train our Physician Partners to deploy them in their practice. This is bringing about a whole new category in the Integrative Medicine world. We stay focused on solutions that utilize natural and autologous products versus those with a majority of drug related treatments. Our new web site http://www.regenomedix.com will be the home to this entire division.”

Located in South Florida Zizion is focused on providing medical professionals with some of the latest products and services helping them to add a cash component to their practice. Platelet Rich Plasma has proven to be effective in trials when treating tendon repair, Articular Cartilage Avulsion, Hamstring tears, Plantar Fasciitis, ACL repair, chronic wounds and soft tissue injuries. PRP uses components of the patient’s own blood to instigate the body to heal itself, the treatment has been used by professional athletes who play for the NFL, PGA, NBA and others.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bruce Bertman
Zizion Group
+1 (561) 221-1000 Ext: 201
Email >

Bruce Bertman
Zizion Group
561.221.1000 201
Email >
Visit website